- 301. Formebolone
- (UMLS (NCI) C0060670) =Steroid; Pharmacologic Substance ;
| - 351. Foster child
- (UMLS (HL7) C1548655) =Idea or Concept =Patient_s Relationship to Insured;
|
- 302. Former Smoker
- [A person who was not smoking at the time of the interview but has smoked at least 100 cigarettes in their life. ( NCI )] (UMLS (NCI) C0337671) =Population Group ;
| - 352. foster child
- [The player of the role is a child receiving parental care and nurture from the scoping person (parent) but not related to him or her through legal or blood ties. ( HL7V3.0 )] (UMLS (HL7) C1609065) =Intellectual Product =Child;
=foster daughter;
foster son |
- 303. formicid
- [ ] (UMLS (CSP) C0598638) =Invertebrate ;
| - 353. foster daughter
- [The player of the role is a female child receiving parental care and nurture from the scoping person (parent) but not related to him or her through legal or blood ties. ( HL7V3.0 )] (UMLS (HL7) C1609618) =Intellectual Product =foster child;
|
- 304. formininotransferase
- [enzyme subclass containing hydroxymethyl-, formyl- and related transferases. ( CSP )] (UMLS (CSP) C0524992) =Amino Acid, Peptide, or Protein; Enzyme =1 carbon transferase;
| - 354. foster home
- [ ] (UMLS (CSP) C0599761) =Manufactured Object ;
|
- 305. Formol
- (UMLS (NCI) C0016584) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 355. foster parent
- [ ] (UMLS (CSP) C0337468) =Family Group
|
- 306. formulary
- [This substitution must be performed based on formulary guidelines. Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological effect. ( HL7V3.0 )] (UMLS (HL7) C1553526) =Health Care Activity =ActSubstanceAdminSubstitutionCode;
| - 356. foster son
- [The player of the role is a male child receiving parental care and nurture from the scoping person (parent) but not related to him or her through legal or blood ties. ( HL7V3.0 )] (UMLS (HL7) C1619820) =Intellectual Product =foster child;
|
- 307. formulary policy
- [Indicates that the decision to substitute or to not substitute was driven by a policy expressed within the formulary. ( HL7V3.0 )] (UMLS (HL7) C1553905) =Idea or Concept =SubstanceAdminSubstitutionReason;
| - 357. FOSTER-KENNEDY SYNDROME
- (UMLS (ICD9CM) C0152112) =Disease or Syndrome ;
|
- 308. Formulary Status
- (UMLS (HL7) C1547856) =Idea or Concept =HL7 Vocabulary Version 2.5;
=This observation/service is on the formulary, and has guidelines;
This observation/service is not on the formulary;
This observation/service is on the formulary, but is restricted;
This observation/service is on the formulary;
Pharmaceutical substance is in the formulary, but guidelines apply;
Pharmaceutical substance is NOT in the formulary;
Pharmaceutical substance is in the formulary, but restrictions apply;
Pharmaceutical substance is in the formulary | - 358. Fouchet stain
- [Stain, Fouchet ( HL7V3.0 )] (UMLS (HL7) C1293974) =Laboratory Procedure =ObservationMethod;
|
- 309. formycin
- [Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties. ( MSH )] (UMLS (CSP) C0016595) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=pyrimidine nucleoside;
ribonucleoside =Coformycin;
| - 359. FOUNDLING HEALTH CARE
- (UMLS (ICD9CM) C1398683) Health supervision of foundling;
=Finding |
- 310. formyl peptide
- [ ] (UMLS (CSP) C0599099) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 360. Four Corners hantavirus
- [causes hantavirus pulmonary syndrome; transmitted by inhaling aerosolized rodent secretions; carried by Peromyscus species. ( CSP )] (UMLS (CSP) C0729678) Sin Nombre virus =Virus =Hantavirus;
|
- 311. Formyl Peptide Receptor 1 Gene
- [This gene plays a role in G protein-coupled receptor signal transduction and chemotaxis. ( NCI )] (UMLS (NCI) C1333574) FPR1;
FPR1 Gene =Gene or Genome | - 361. Four times a day
- [Four times per day. (NCI) ( NCI )] (UMLS (NCI) C0585291) =Temporal Concept =GTSAbbreviation;
|
- 312. formylmethionine
- [Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells. ( MSH )] (UMLS (CSP) C0027228) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 362. four times a day at institution-specified times
- (UMLS (HL7) C1548625) =Temporal Concept =Repeat;
|
- 313. formyltetrahydrofolate
- [Tetrahydrofolates which are substituted by a formyl group at either the nitrogen atom in the 5 position or the nitrogen atom in the 10 position. N(5)-Formyltetrahydrofolate is leukovorin (citrovorum factor) while N(10)-formyltetrahydrofolate is an active coenzyme which functions as a carrier of the formyl group in a number of enzymatic reactions. ( MSH )] (UMLS (CSP) C0016598) =Organic Chemical; Vitamin ;
=Tetrahydrofolates;
=5-Formyl-5,6,7,8-tetrahydrofolic Acid;
| - 363. Four times a week
- [Four times per week. ( NCI )] (UMLS (NCI) C0585297) =Temporal Concept
|
- 314. formyltetrahydrolfolate synthase
- [ ] (UMLS (CSP) C0598055) =Amino Acid, Peptide, or Protein; Enzyme
| - 364. Fourchette
- (UMLS (HL7) C0458840) =Body Part, Organ, or Organ Component =Body Part;
|
- 315. Forodesine
- [The hydrochloride salt of the synthetic high-affinity transition-state analogue forodesine. Forodesine binds preferentially to and inhibits purine nucleotide phosphorylase (PNP), resulting in the accumulation of deoxyguanosine triphosphate and the subsequent inhibition of the enzyme ribonucleoside diphosphate reductase and DNA synthesis. This agent selectively causes apoptosis in stimulated or malignant T-lymphocytes. A transition state analogue is a substrate designed to mimic the properties or the geometry of the transition state of reaction. ( NCI )] (UMLS (NCI) C0676720) =Organic Chemical; Pharmacologic Substance ;
| - 365. Fourier transform infrared spectrometry
- [ ] (UMLS (CSP) C0920528) =Laboratory Procedure
|
- 316. forskolin
- [saturated, polymethylated naphthopyran which stimulates adenylate cyclase and so is used to probe cyclic AMP pathways; USP lists colfosin as antiglaucoma agent. ( CSP )] (UMLS (CSP) C0016601) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =diterpene;
antiglaucoma drug | - 366. Fourier transform infrared spectroscopy
- [A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained. ( MSH )] (UMLS (CSP) C0206055) =Research Activity ;
|
- 317. Forssman antibody
- [ ] (UMLS (CSP) C0016602) =Immunologic Factor
| - 367. Fourier transform spectroscopy
- [ ] (UMLS (CSP) C0599826) =Laboratory Procedure ;
|
- 318. Fort Belknap Indian Community of the Fort Belknap
- (UMLS (HL7) C1554304) =Population Group =NativeEntityContiguous;
| - 368. Fourth
- [Following the third position in an ordering or series; coming next after the third and just before the fifth in position. ( NCI )] (UMLS (NCI) C0205438) =Quantitative Concept
|
- 319. Fort Bidwell Indian Community of the Fort Bidwell
- (UMLS (HL7) C1554305) =Population Group =NativeEntityContiguous;
| - 369. Fourth Cranial Nerve Neoplasm
- (UMLS (NCI) C1263896) Fourth Cranial Nerve Neoplasms;
Fourth Cranial Nerve Tumor;
Fourth Cranial Nerve Tumors;
IVth Cranial Nerve Neoplasms;
IVth Cranial Nerve Tumors;
Neoplasm of Fourth Cranial Nerve;
Neoplasm of the Fourth Cranial Nerve;
Neoplasm of the Trochlear Nerve;
Neoplasm of Trochlear Nerve;
Trochlear Nerve Neoplasm;
Trochlear Nerve Neoplasms;
Trochlear Nerve Tumor;
Trochlear Nerve Tumors;
Tumor of Fourth Cranial Nerve;
Tumor of the Fourth Cranial Nerve;
Tumor of the Trochlear Nerve;
Tumor of Trochlear Nerve;
=Neoplastic Process |
- 320. Fort Independence Indian Community of Paiute India
- (UMLS (HL7) C1554306) =Population Group =NativeEntityContiguous;
| - 370. FOURTH NERVE PALSY
- (UMLS (ICD9CM) C0152176) =Disease or Syndrome
|
- 321. Fort McDermitt Paiute and Shoshone Tribes of the F
- (UMLS (HL7) C1554307) =Population Group =NativeEntityContiguous;
| - 371. Fourth Pharyngeal Pouch
- (UMLS (NCI) C0231071) =Embryonic Structure
|
- 322. Fort McDowell Yavapai Nation, Arizona (formerly th
- (UMLS (HL7) C1554308) =Population Group =NativeEntityContiguous;
| - 372. fourth ventricle
- [An irregularly shaped cavity in the rhombencephalon, between the medulla oblongata, the pons, and the isthmus in front, and the cerebellum behind. It is continuous with the central canal of the cord below and with the CEREBRAL AQUEDUCT above, and through its lateral and median apertures it communicates with the subarachnoid space. ( MSH )] (UMLS (CSP) C0149556) =Body Space or Junction
|
- 323. Fort Mojave Indian Tribe of Arizona, California
- (UMLS (HL7) C1554309) =Population Group =NativeEntityContiguous;
| - 373. Fourth Ventricle Ependyma
- (UMLS (NCI) C0228171) =Body Part, Organ, or Organ Component
|
- 324. Fort Morgan virus
- [ ] (UMLS (CSP) C0318736) =Virus
| - 374. Fourth Way
- (UMLS (HL7) C1552047) =Idea or Concept =Religious Affiliation;
|
- 325. Fort Sill Apache Tribe of Oklahoma
- (UMLS (HL7) C1554310) =Population Group =NativeEntityContiguous;
| - 375. Fovea
- [area within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer; includes the sloping walls of the fovea (clivus) and contains a few rods in its periphery; in its center (foveola) are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. ( CSP )] (UMLS (NCI) C0016622) =Body Part, Organ, or Organ Component =Eye - Retina (MMHCC);
|
- 326. Fortaz
- (UMLS (NCI) C0700859) =Organic Chemical; Antibiotic ;
| - 376. Foveolar Hyperplasia
- (UMLS (NCI) C1333636) =Pathologic Function ;
|
- 327. Fortecortin
- (UMLS (NCI) C0525283) =Steroid; Pharmacologic Substance
| - 377. fowl adenovirus 1
- [A serotype of the species Fowl adenovirus A. ( MSH )] (UMLS (CSP) C0242169) =Virus
|
- 328. FOS Family Gene
- [FOS Family Genes encode nuclear leucine zipper FOS Family Proteins (FOS, FOSB, FOSL1, and FOSL2) that can dimerize with JUN Family proteins and bind DNA as the AP-1 transcription factor complex to regulate transcription in cell proliferation, differentiation, and transformation. (NCI) ( NCI )] (UMLS (NCI) C0085303) =Gene or Genome
| - 378. fowl paralysis
- [highly contagious virus disease of poultry that is characterized especially by proliferation of lymphoid cells and is caused by a herpesvirus having several serotypes. ( CSP )] (UMLS (CSP) C0024793) =Neoplastic Process ;
=Herpesviridae disease;
lymphoma;
Lymphoproliferative Disorder;
Tumor Virus Infections |
- 329. Fosamax
- (UMLS (NCI) C0376569) =Organophosphorus Compound; Pharmacologic Substance ;
| - 379. Fowler's Position
- [A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 to 60 degrees. Knees may or may not be bent. ( NCI )] (UMLS (NCI) C0277811) =Spatial Concept
|
- 330. Foscan
- (UMLS (NCI) C0701505) =Organic Chemical; Pharmacologic Substance
| - 380. Fowlpox Vaccine
- [A recombinant virus-based vaccine that contains various peptide antigens. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. Strong CD8 T cell responses may be induced after prolonged immunization and have been associated with tumor regression. ( NCI )] (UMLS (NCI) C0796601) Fowlpox Virus Vaccine =Pharmacologic Substance; Immunologic Factor ;
|
- 331. foscarnet
- [phosphonoformate (trisodium); anticytomegaloviral agent with potential for treating AIDS retinopathy. ( CSP )] (UMLS (CSP) C0070895) =Organophosphorus Compound; Pharmacologic Substance =[AM800] ANTIVIRALS;
Phosphonoacetic Acid;
phosphonate;
=FOSCARNET SODIUM HEXAHYDRATE | - 381. fowlpox virus
- [The type species of the genus AVIPOXVIRUS. It is the etiologic agent of FOWLPOX. ( MSH )] (UMLS (CSP) C0016630) =Virus
|
- 332. FOSCARNET SODIUM
- [A synthetic organic analogue of inorganic pyrophosphate with antiviral properties. Foscarnet (trisodium phosphonoformate) selectively blocks the pyrophosphate binding site of virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases. Because this agent crosses the blood brain barrier, it may be used in the treatment of viral infections of the CNS. (NCI04) ( NCI )] (UMLS (NCI) C0146934) =Organophosphorus Compound; Pharmacologic Substance
| - 382. fowlpox virus vaccine vector/gp100 antigen/interleukin-2
- (UMLS (NCI) C1134602) Fowlpox Virus Vaccine/gp100 Antigen/Interleukin-2 =Therapeutic or Preventive Procedure
|
- 333. foscavir
- [ ] (UMLS (CSP) C0730991) =Organophosphorus Compound; Pharmacologic Substance ;
| - 383. Fowlpox Virus Vaccine/Interleukin-2
- (UMLS (NCI) C0796602) FOWLVAC/IL-2 =Therapeutic or Preventive Procedure
|
- 334. FOSFOCREATININE
- (UMLS (NCI) C0070826) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 384. Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine
- (UMLS (NCI) C0796658) =Therapeutic or Preventive Procedure
|
- 335. Fosfosal
- (UMLS (NCI) C0045981) =Organophosphorus Compound; Pharmacologic Substance ;
| - 385. fowlpox-CEA-B7.1/ICAM-1/LFA-3
- [A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. (NCI04) ( NCI )] (UMLS (NCI) C0935790) Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine;
Recombinant Fowlpox-CEA-TRICOM Vaccine;
rF-CEA(6D)TRICOM;
=Pharmacologic Substance; Immunologic Factor ;
|
- 336. FOSINOPRIL
- [A phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As an ester prodrug, fosinopril is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase in water outflow. ( NCI )] (UMLS (NCI) C0118168) =Organophosphorus Compound; Pharmacologic Substance =[CV800] ACE INHIBITORS;
Organophosphorus Compounds;
PROLINE;
=Eliten;
FOSINOPRIL 20 MG | - 386. Fowlpox-CEA-TRICOM Vaccine/Sargramostim
- (UMLS (NCI) C1134687) =Therapeutic or Preventive Procedure
|
- 337. Fosinoprilat
- [A phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase in water outflow. ( NCI )] (UMLS (NCI) C0075061) =Organophosphorus Compound; Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 387. Fowlpox-CEA-TRICOM Vaccine/Sargramostim/Vaccinia-CEA-TRICOM Vaccine
- (UMLS (NCI) C1134693) =Therapeutic or Preventive Procedure ;
|
- 338. FOSL1
- [This gene plays a role in osteoclast differentiation and transcriptional activation. ( NCI )] (UMLS (NCI) C0812299) FOSL1 Gene;
FOS-Like Antigen 1 Gene =Gene or Genome | - 388. Fowlpox-CEA-TRICOM Vaccine/Vaccinia-CEA-TRICOM Vaccine
- (UMLS (NCI) C1134692) =Therapeutic or Preventive Procedure ;
|
- 339. FOSL2
- [This gene is involved in cellular proliferation and apoptosis. ( NCI )] (UMLS (NCI) C0812302) FOSL2 Gene;
FOS-Like Antigen 2 Gene =Gene or Genome | - 389. Fowlpox-PSA Vaccine
- [A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04) ( NCI )] (UMLS (NCI) C1134640) Recombinant Fowlpox-Prostate Specific Antigen;
Recombinant Fowlpox-Prostate Specific Antigen Vaccine;
Recombinant Fowlpox-PSA;
Recombinant Fowlpox-PSA Vaccine;
rF-PSA =Pharmacologic Substance; Immunologic Factor ;
|
- 340. FOSL2
- [A possible nuclear hetero-dimeric protein that belongs to the bZIP family. FOSL2 protein can dimerize with JUN family proteins to form the transcription factor AP-1 complex and is a possible regulator of cell proliferation, differentiation, and transformation. (from SWISS-PROT P15408, OMIM 601575, and NCI) ( NCI )] (UMLS (NCI) C1312389) FOSL2 Protein;
FOS-Like Antigen 2 Protein;
FOS-Related Antigen 2 Protein;
FRA2 Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 390. Fowlpox-PSA Vaccine/Sargramostim
- (UMLS (NCI) C1327775) =Therapeutic or Preventive Procedure ;
|
- 341. Fosmidomycin
- (UMLS (NCI) C0060694) =Organic Chemical; Antibiotic ;
| - 391. Fowlpox-PSA-TRICOM Vaccine
- [Synthetic fowlpox viral vaccines containing a tumor-associated antigen derived from prostate specific antigen (PSA), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3). Vaccination with this viral vaccine may enhance antigen presentation and activate cytotoxic T-cells against PSA-expressing tumor cells. ( NCI )] (UMLS (NCI) C1327972) fPSA-TRI =Pharmacologic Substance; Immunologic Factor
|
- 342. Fosphenytoin
- (UMLS (NCI) C0244656) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
5,5-Diphenyl-2,4-imidazolidinedione =2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, Disodium Salt | - 392. Fowlpox-PSA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327976) =Therapeutic or Preventive Procedure ;
|
- 343. FOSQUIDONE
- [A pentacyclic pyrolloquinone and an analogue of mitoquidone with anticancer activity. Although the mechanism has not been fully elucidated, fosquidone's antineoplastic activity may be attributed to DNA intercalation or by binding to the minor groove of DNA. In addition, bioreduction of fosquidone's quinine group, resulting in redox cycling, and generation of a cascade of reactive oxygen species, has been suggested to result in DNA damage and/or lipid peroxidation. ( NCI )] (UMLS (NCI) C0118171) =Organic Chemical; Pharmacologic Substance
| - 393. Fowlpox-PSA-TRICOM Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327975) =Therapeutic or Preventive Procedure ;
|
- 344. Fossa
- [A concavity in a surface, especially an anatomical depression. ( NCI )] (UMLS (NCI) C0836913) =Body Space or Junction
| - 394. Fowlpox-PSA-TRICOM Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327974) =Therapeutic or Preventive Procedure ;
|
- 345. Fossa of Antihelix
- (UMLS (NCI) C0931627) Fossa of the Antihelix;
Fossa Triangularis =Body Space or Junction | - 395. Fowlpox-Sargramostim
- [A cancer vaccine adjuvant consisting of a recombinant fowlpox virus encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to specific cell surface receptors on various immuno-hematopoietic cell types, enhancing their proliferation and differentiation and stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Administration of recombinant fowlpox GM-CSF vaccine adjuvant may induce an immune response against tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. ( NCI )] (UMLS (NCI) C1134686) Recombinant Fowlpox GM-CSF Vaccine Adjuvant;
rF-GM-CSF;
rF-Sargramostim =Pharmacologic Substance; Immunologic Factor ;
|
- 346. Fossa of Helix
- (UMLS (NCI) C0458629) =Body Location or Region
| - 396. Fowlpox-Sargramostim Vaccine/Fowlpox-TRICOM Vaccine
- (UMLS (NCI) C1328078) =Therapeutic or Preventive Procedure ;
|
- 347. fossil fuel energy
- [hydrocarbon deposits that consist of the remains of animal or vegetable life from past geologic ages, now in a combustible form suitable for use as fuel. ( CSP )] (UMLS (CSP) C0178644) =Functional Concept =energy source;
=coal;
petroleum oil;
| - 397. Fowlpox-Tyrosinase Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine
- (UMLS (NCI) C1327885) =Therapeutic or Preventive Procedure ;
|
- 348. foster care
- [ ] (UMLS (CSP) C0419195) =Family Group
| - 398. fox
- [Any of several carnivores in the family CANIDAE, that possess erect ears and long bushy tails and are smaller than WOLVES. They are classified in several genera and found on all continents except Antarctica. ( MSH )] (UMLS (CSP) C0016633) =Mammal
|
- 349. foster care facility
- [ ] (UMLS (CSP) C0599759) =Manufactured Object ;
| - 399. Fox Terrier (Smooth)
- [The Smooth Fox Terrier is a little dog with a short white coat and black or brown markings. It has a flat, tapering, narrow skull, and ears that fold forward making "V" shaped flaps. It has strong jaws and well-developed teeth. Height: 13-16 inches (33-41 cm.) Weight: 13-20 pounds (6-9 kg.) ( NCI )] (UMLS (NCI) C0324366) =Mammal
|
- 350. Foster child
- (UMLS (HL7) C1546501) =Idea or Concept =Association;
| - 400. Fox Terrier (Wire)
- [The Wirehaired Fox Terrier is a small, strong dog with a wiry coat with black or brown markings. The breed has a flat, tapering, narrow skull, and ears that fold forward making "V" shaped flaps. Height: 13-16 inches (33-41 cm.) Weight: 13-20 pounds (6-9 kg.) ( NCI )] (UMLS (NCI) C0324367) =Mammal
|
home
